US Glaucoma Surgery Market

ID: MRFR/MED/17433-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026
US Glaucoma Surgery Market Research Report By Target (Trabecular meshwork, Suprachoroidal space, Others), By Type of surgery (Angle closure glaucoma surgery, Aqueous shunt surgery, laser surgery, Others) and By End User (Hospital, Ambulatory surgery centers, Others) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Glaucoma Surgery Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)6.1%
2024 Market Size$ 178.85 Million
2025 Market Size$ 191.1 Million
2035 Market Size$ 343 Million

Key Players

Alcon
AbbVie
Bausch + Lomb
Glaukos
Carl Zeiss
Santen
Trends
  • Minimally Invasive Techniques
  • Personalized Treatment Approaches
  • Regulatory Advancements
Opportunities
  • Aging Population
  • Technological Advancements
  • Rising Healthcare Expenditure
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Surgery Type (USD Million)
      1. 4.1.1 Trabeculectomy
      2. 4.1.2 Tube Shunt Surgery
      3. 4.1.3 Minimally Invasive Glaucoma Surgery
      4. 4.1.4 Laser Surgery
      5. 4.1.5 Cataract Surgery with Glaucoma Treatment
    2. 4.2 Healthcare, BY Patient Demographics (USD Million)
      1. 4.2.1 Age Group
      2. 4.2.2 Gender
      3. 4.2.3 Ethnicity
      4. 4.2.4 Socioeconomic Status
      5. 4.2.5 Insurance Coverage
    3. 4.3 Healthcare, BY Surgical Technique (USD Million)
      1. 4.3.1 Traditional Surgery
      2. 4.3.2 Endoscopic Surgery
      3. 4.3.3 Robotic Surgery
      4. 4.3.4 Laser-Assisted Surgery
      5. 4.3.5 Combined Surgery
    4. 4.4 Healthcare, BY Postoperative Care (USD Million)
      1. 4.4.1 Follow-Up Visits
      2. 4.4.2 Medication Management
      3. 4.4.3 Rehabilitation Services
      4. 4.4.4 Patient Education
      5. 4.4.5 Complications Management
    5. 4.5 Healthcare, BY Market Dynamics (USD Million)
      1. 4.5.1 Regulatory Environment
      2. 4.5.2 Technological Advancements
      3. 4.5.3 Market Trends
      4. 4.5.4 Competitive Landscape
      5. 4.5.5 Patient Awareness
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Alcon (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 AbbVie (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bausch + Lomb (CA)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Glaukos (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Carl Zeiss (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Santen (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Johnson & Johnson (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Merck (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Novartis (CH)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY SURGERY TYPE
    3. 6.3 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    4. 6.4 US MARKET ANALYSIS BY SURGICAL TECHNIQUE
    5. 6.5 US MARKET ANALYSIS BY POSTOPERATIVE CARE
    6. 6.6 US MARKET ANALYSIS BY MARKET DYNAMICS
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY SURGERY TYPE, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY SURGERY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY MARKET DYNAMICS, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY MARKET DYNAMICS, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SURGERY TYPE, 2026-2035 (USD Million)
      2. 7.2.2 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
      3. 7.2.3 BY SURGICAL TECHNIQUE, 2026-2035 (USD Million)
      4. 7.2.4 BY POSTOPERATIVE CARE, 2026-2035 (USD Million)
      5. 7.2.5 BY MARKET DYNAMICS, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Glaucoma Surgery Market Segmentation

US Glaucoma Surgery Market By Surgery Type (USD Million, 2026-2035)

  • Trabeculectomy
  • Tube Shunt Surgery
  • Minimally Invasive Glaucoma Surgery
  • Laser Surgery
  • Cataract Surgery with Glaucoma Treatment

US Glaucoma Surgery Market By Patient Demographics (USD Million, 2026-2035)

  • Age Group
  • Gender
  • Ethnicity
  • Socioeconomic Status
  • Insurance Coverage

US Glaucoma Surgery Market By Surgical Technique (USD Million, 2026-2035)

  • Traditional Surgery
  • Endoscopic Surgery
  • Robotic Surgery
  • Laser-Assisted Surgery
  • Combined Surgery

US Glaucoma Surgery Market By Postoperative Care (USD Million, 2026-2035)

  • Follow-Up Visits
  • Medication Management
  • Rehabilitation Services
  • Patient Education
  • Complications Management

US Glaucoma Surgery Market By Market Dynamics (USD Million, 2026-2035)

  • Regulatory Environment
  • Technological Advancements
  • Market Trends
  • Competitive Landscape
  • Patient Awareness

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035